Yn dangos 76 i 90 o 363 canlyniadau
Statement on physiotherapist renewals
Statement on physiotherapist renewals from Andrew Smith, Executive Director of Regulation
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)
HCPC response to PSA Performance Review
HCPC welcomes recognition of progress on key areas of activity and sets out plan for further improvement
What you need to know about being an expert witness
Being an expert witness is an opportunity to demonstrate high levels of expertise and professionalism in your own area of practise
Launch of consultation for the standards of conduct, performance and ethics
Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.
Closure of the COVID-19 Temporary Register
The COVID-19 Temporary Register will close on the 31 March 2024.